<\/p>
Authorisation of a veterinary medicine involves an assessment of the benefits of a product against its risks. Potential risks include risks to the animal, to the user, the consumer and to the environment. The environmental risk is assessed to establish the extent of exposure. If the environmental exposure is not extensive, then no further assessment is required. Without exposure, there is no risk irrespective of the toxicity. If there is information in the public domain to indicate that despite low exposure there may be a potential risk, then the competent authority \u2013 the body that authorises veterinary medicines - can request a further assessment of the issues identified.<\/p>
<\/p>
<\/p>
<\/p>
Products containing Diclofenac are a risk to vultures if there is any exposure of the birds to carcasses of animals containing residues of the veterinary medicine. The toxicity of Diclofenac to vultures is well documented. In Europe there are laws which provide for the disposal of fallen stock. The risk of exposure is therefore minimal as dead farmed animals are not left in the fields. Risk mitigation measures (instructions to the users) could be used to eliminate exposure by instructing users not to feed carcasses of animals treated with Diclofenac to vultures. This is something for the competent authorities of those Member States that have authorised the veterinary use of Diclofenac. The Government has no evidence that there is a serious risk to vultures posed by the authorisation of Diclofenac and therefore does not plan to trigger a referral procedure.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2202", "label" : {"_value" : "Biography information for Lord De Mauley"} } , "answeringMemberPrinted" : {"_value" : "Lord De Mauley"} , "dateOfAnswer" : {"_value" : "2014-07-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL1052"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-17T12:02:30.3786344Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2014-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Birds of Prey"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how they will respond to the recent licensing of the drug diclofenac in two Member States of the European Union; and what assessment they have made of its toxicity to vultures.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4260", "label" : {"_value" : "Biography information for Lord Trees"} } , "tablingMemberPrinted" : [{"_value" : "Lord Trees"} ], "uin" : "HL1051"} , {"_about" : "http://data.parliament.uk/resources/77318", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77318/answer", "answerText" : {"_value" : "
<\/p>
Authorisation of a veterinary medicine involves an assessment of the benefits of a product against its risks. Potential risks include risks to the animal, to the user, the consumer and to the environment. The environmental risk is assessed to establish the extent of exposure. If the environmental exposure is not extensive, then no further assessment is required. Without exposure, there is no risk irrespective of the toxicity. If there is information in the public domain to indicate that despite low exposure there may be a potential risk, then the competent authority \u2013 the body that authorises veterinary medicines - can request a further assessment of the issues identified.<\/p>
<\/p>
<\/p>
<\/p>
Products containing Diclofenac are a risk to vultures if there is any exposure of the birds to carcasses of animals containing residues of the veterinary medicine. The toxicity of Diclofenac to vultures is well documented. In Europe there are laws which provide for the disposal of fallen stock. The risk of exposure is therefore minimal as dead farmed animals are not left in the fields. Risk mitigation measures (instructions to the users) could be used to eliminate exposure by instructing users not to feed carcasses of animals treated with Diclofenac to vultures. This is something for the competent authorities of those Member States that have authorised the veterinary use of Diclofenac. The Government has no evidence that there is a serious risk to vultures posed by the authorisation of Diclofenac and therefore does not plan to trigger a referral procedure.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2202", "label" : {"_value" : "Biography information for Lord De Mauley"} } , "answeringMemberPrinted" : {"_value" : "Lord De Mauley"} , "dateOfAnswer" : {"_value" : "2014-07-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL1051"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-17T12:02:31.0662145Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2014-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Birds of Prey"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether they plan to trigger a European Union referral procedure for the drug diclofenac in view of its recent registration in two Member States of the European Union and its toxicity to vultures.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4260", "label" : {"_value" : "Biography information for Lord Trees"} } , "tablingMemberPrinted" : [{"_value" : "Lord Trees"} ], "uin" : "HL1052"} , {"_about" : "http://data.parliament.uk/resources/77319", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77319/answer", "answerText" : {"_value" : "
There is a delay in funding as schools are generally funded for the number of pupils they had based on the previous year\u2019s school census. This provides schools with greater stability and predictability in planning their budgets. However, we are aware of the difficulties that some schools experiencing an influx of pupils after the start of an academic year can face. This is why local authorities can use a mobility factor in their local funding formula to give additional funding to schools that have a large number of pupils entering at non-standard entry times. We have also given local authorities the option of setting up a growth fund, which can support schools taking on more pupils because of the need for extra places in the area.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4270", "label" : {"_value" : "Biography information for Lord Nash"} } , "answeringMemberPrinted" : {"_value" : "Lord Nash"} , "dateOfAnswer" : {"_value" : "2014-07-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-21T15:02:48.6212372Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2014-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Schools: Finance"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what mechanisms are in place to ensure that there is no delay in the provision of funding for a pupil who moves school after the start of a new academic year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4196", "label" : {"_value" : "Biography information for Lord Sharkey"} } , "tablingMemberPrinted" : [{"_value" : "Lord Sharkey"} ], "uin" : "HL1053"} , {"_about" : "http://data.parliament.uk/resources/77321", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77321/answer", "answerText" : {"_value" : "
In June 2013 the Shah Deniz consortium announced the selection of the Trans Adriatic Pipeline to transport Azerbaijani gas to European markets. The UK strongly supports the development of the southern gas corridor, and the then Secretary of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for Richmond (Yorks) (Mr Hague), visited Azerbaijan on 17 December 2013 to attend the Final Investment Decision (FID) signing ceremony for the second phase of the Shah Deniz gas field. We remain in close contact with governments along the route, as well as the companies involved in Shah Deniz and the Trans Anatolian and Trans Adriatic pipelines. These projects are not affected by EU sanctions against Russia.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3839", "label" : {"_value" : "Biography information for Baroness Warsi"} } , "answeringMemberPrinted" : {"_value" : "Baroness Warsi"} , "dateOfAnswer" : {"_value" : "2014-07-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-21T13:16:40.5903661Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2014-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Natural Gas: Pipelines"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what is their assessment of the development of the Nabucco pipeline and the Trans Adriatic Pipeline; and how they are affected by European Union sanctions against Russia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3496", "label" : {"_value" : "Biography information for Lord Bowness"} } , "tablingMemberPrinted" : [{"_value" : "Lord Bowness"} ], "uin" : "HL1055"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 4, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }